# A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer

> **NCT07483307** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 176 (estimated)

## Conditions studied

- Breast Cancer
- HER2-negative Breast Cancer
- HER2 Negative Breast Carcinoma
- ER+ Breast Cancer

## Interventions

- **DRUG:** Neoadjuvant endocrine therapy

## Key facts

- **NCT ID:** NCT07483307
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-13
- **Primary completion:** 2030-03-13
- **Final completion:** 2030-03-13
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07483307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07483307, "A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07483307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*